These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24977972)

  • 1. Plasma chemerin levels in patients with multiple sclerosis.
    Tomalka-Kochanowska J; Baranowska B; Wolinska-Witort E; Uchman D; Litwiniuk A; Martynska L; Kalisz M; Bik W; Kochanowski J
    Neuro Endocrinol Lett; 2014; 35(3):218-23. PubMed ID: 24977972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.
    Ademoglu E; Berberoglu Z; Carlioglu A; Dellal F; Gorar S; Alphan Z; Uysal S; Karakurt F
    Minerva Ginecol; 2014 Dec; 66(6):535-42. PubMed ID: 25373013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects.
    Sledzinski T; Korczynska J; Hallmann A; Kaska L; Proczko-Markuszewska M; Stefaniak T; Sledzinski M; Swierczynski J
    J Endocrinol Invest; 2013 Jun; 36(6):428-34. PubMed ID: 23211604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo.
    Bauer S; Bala M; Kopp A; Eisinger K; Schmid A; Schneider S; Neumeier M; Buechler C
    Eur J Clin Invest; 2012 Nov; 42(11):1213-20. PubMed ID: 22924572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Plasma Chemerin Concentrations and Bone Quality in Adults From the General Population.
    Kadric L; Zylla S; Nauck M; Völzke H; Friedrich N; Hannemann A
    Endocrinology; 2018 Jun; 159(6):2378-2385. PubMed ID: 29701774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome.
    Guzel EC; Celik C; Abali R; Kucukyalcin V; Celik E; Guzel M; Yilmaz M
    Gynecol Endocrinol; 2014 Jun; 30(6):419-22. PubMed ID: 24524360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women.
    Faramarzi M; Banitalebi E; Nori S; Farzin S; Taghavian Z
    J Sports Med Phys Fitness; 2016 Apr; 56(4):476-82. PubMed ID: 25651894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep.
    Daxer J; Herttrich T; Zhao YY; Vogel M; Hiemisch A; Scheuermann K; Körner A; Kratzsch J; Kiess W; Quante M
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):57-61. PubMed ID: 27941174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum chemerin in children with excess body weight may be associated with ongoing metabolic complications - A pilot study.
    Sledzińska M; Szlagatys-Sidorkiewicz A; Brzezinski M; Kaźmierska K; Sledziński T; Kamińska B
    Adv Med Sci; 2017 Sep; 62(2):383-386. PubMed ID: 28551507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemerin is a novel adipokine associated with obesity and metabolic syndrome.
    Bozaoglu K; Bolton K; McMillan J; Zimmet P; Jowett J; Collier G; Walder K; Segal D
    Endocrinology; 2007 Oct; 148(10):4687-94. PubMed ID: 17640997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chemerin, lipid profile, and insulin resistance on disease parameters in patients with multiple sclerosis.
    Koskderelioglu A; Gedizlioglu M; Eskut N; Tamer P; Yalcin G; Bozkaya G
    Neurol Sci; 2021 Jun; 42(6):2471-2479. PubMed ID: 33097973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients.
    Gu P; Jiang W; Lu B; Shi Z
    Clin Exp Hypertens; 2014; 36(5):326-32. PubMed ID: 24047472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adipokine Chemerin and Fetuin-A Serum Levels in Type 2 Diabetes Mellitus: Relation to Obesity and Inflammatory Markers.
    El-Deeb TS; Bakkar SM; Eltoony L; Zakhary MM; Kamel AA; Nafee AM; Hetta HF
    Egypt J Immunol; 2018 Jan; 25(1):191-202. PubMed ID: 30243011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
    Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
    Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population.
    Bozaoglu K; Segal D; Shields KA; Cummings N; Curran JE; Comuzzie AG; Mahaney MC; Rainwater DL; VandeBerg JL; MacCluer JW; Collier G; Blangero J; Walder K; Jowett JB
    J Clin Endocrinol Metab; 2009 Aug; 94(8):3085-8. PubMed ID: 19470637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating chemerin level is independently correlated with arterial stiffness.
    Yoo HJ; Choi HY; Yang SJ; Kim HY; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
    J Atheroscler Thromb; 2012; 19(1):59-66; discussion 67-8. PubMed ID: 22104178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemerin as a mediator between obesity and vascular inflammation in children.
    Landgraf K; Friebe D; Ullrich T; Kratzsch J; Dittrich K; Herberth G; Adams V; Kiess W; Erbs S; Körner A
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E556-64. PubMed ID: 22438234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.
    Chakaroun R; Raschpichler M; Klöting N; Oberbach A; Flehmig G; Kern M; Schön MR; Shang E; Lohmann T; Dreßler M; Fasshauer M; Stumvoll M; Blüher M
    Metabolism; 2012 May; 61(5):706-14. PubMed ID: 22136911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome.
    Hamza RT; Elkabbany ZA; Shedid AM; Hamed AI; Ebrahim AO
    Arch Med Res; 2016 Oct; 47(7):541-549. PubMed ID: 28262196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.